141 related articles for article (PubMed ID: 38492843)
81. Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.
Angrish MM; Jones AD; Harkema JR; Zacharewski TR
Toxicol Sci; 2011 Dec; 124(2):299-310. PubMed ID: 21890736
[TBL] [Abstract][Full Text] [Related]
82. Effects of phosphatidylethanol on mouse adipocyte differentiation and expression of stearoyl-CoA desaturase 1.
Huusko TJ; Liisanantti MK; Nissinen AE; Kakko S; Savolainen ER; Vuoristo JT; Savolainen MJ
Alcohol Clin Exp Res; 2007 Mar; 31(3):376-82. PubMed ID: 17295720
[TBL] [Abstract][Full Text] [Related]
83. Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1).
Piccinin E; Cariello M; Moschetta A
Mol Aspects Med; 2021 Apr; 78():100933. PubMed ID: 33218679
[TBL] [Abstract][Full Text] [Related]
84. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
85. Hepatic Stearoyl-CoA desaturase-1 deficiency-mediated activation of mTORC1- PGC-1α axis regulates ER stress during high-carbohydrate feeding.
Aljohani A; Khan MI; Syed DN; Abram B; Lewis S; Neill LO; Mukhtar H; Ntambi JM
Sci Rep; 2019 Oct; 9(1):15761. PubMed ID: 31673045
[TBL] [Abstract][Full Text] [Related]
86. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Chu K; Miyazaki M; Man WC; Ntambi JM
Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
[TBL] [Abstract][Full Text] [Related]
87. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.
Raeisi M; Hassanbeigi L; Khalili F; Kharrati-Shishavan H; Yousefi M; Mehdizadeh A
Mol Biol Rep; 2022 Sep; 49(9):8871-8882. PubMed ID: 35906508
[TBL] [Abstract][Full Text] [Related]
88. Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation.
Dalla Valle A; Vertongen P; Spruyt D; Lechanteur J; Suain V; Gaspard N; Brion JP; Gangji V; Rasschaert J
Front Endocrinol (Lausanne); 2019; 10():726. PubMed ID: 31708874
[TBL] [Abstract][Full Text] [Related]
89. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis.
Miyazaki M; Kim YC; Ntambi JM
J Lipid Res; 2001 Jul; 42(7):1018-24. PubMed ID: 11441127
[TBL] [Abstract][Full Text] [Related]
90. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
[TBL] [Abstract][Full Text] [Related]
91. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
92. The green algal carotenoid siphonaxanthin inhibits adipogenesis in 3T3-L1 preadipocytes and the accumulation of lipids in white adipose tissue of KK-Ay mice.
Li ZS; Noda K; Fujita E; Manabe Y; Hirata T; Sugawara T
J Nutr; 2015 Mar; 145(3):490-8. PubMed ID: 25733464
[TBL] [Abstract][Full Text] [Related]
93. Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation.
Stryjecki C; Roke K; Clarke S; Nielsen D; Badawi A; El-Sohemy A; Ma DW; Mutch DM
Mol Genet Metab; 2012 Mar; 105(3):421-7. PubMed ID: 22209225
[TBL] [Abstract][Full Text] [Related]
94. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
95. SCD1, autophagy and cancer: implications for therapy.
Ascenzi F; De Vitis C; Maugeri-Saccà M; Napoli C; Ciliberto G; Mancini R
J Exp Clin Cancer Res; 2021 Aug; 40(1):265. PubMed ID: 34429143
[TBL] [Abstract][Full Text] [Related]
96. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
[TBL] [Abstract][Full Text] [Related]
97. Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer.
Lombardi S; Goldman AR; Tang HY; Kossenkov AV; Liu H; Zhou W; Herlyn M; Lin J; Zhang R
Cancer Res Commun; 2023 Jun; 3(6):1067-1077. PubMed ID: 37377614
[TBL] [Abstract][Full Text] [Related]
98. Increased hydrophilic plasma bile acids are correlated with protection from adiposity in skin-specific stearoyl-CoA desaturase-1 deficient mice.
Dumas SN; Ntambi JM
PLoS One; 2018; 13(7):e0199682. PubMed ID: 29965978
[TBL] [Abstract][Full Text] [Related]
99. Effect of stearoyl-coenzyme a desaturase 1 (SCD1) on the function of mast cells.
Zhang X; Li A; Zhu Y; Liu F; Zhao D; Tang H; Xu C
J Asthma; 2024 Jul; 61(7):707-716. PubMed ID: 38315158
[No Abstract] [Full Text] [Related]
100. Advances in regulation and function of stearoyl-CoA desaturase 1 in cancer, from bench to bed.
Guo Z; Huo X; Li X; Jiang C; Xue L
Sci China Life Sci; 2023 Dec; 66(12):2773-2785. PubMed ID: 37450239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
